Overcoming the oral delivery challenges of venetoclax: advancing a clinically improved Bcl-2 inhibitor. [PDF]
Hegishte Y +3 more
europepmc +1 more source
Influence of Core and Membrane Composition on Drug Release from MCC/Isomalt-Based Matrix Pellets in Biorelevant Osmolarity Media. [PDF]
Fleck C +7 more
europepmc +1 more source
TIM-1 and Tiny-TIM as Robust In Vitro Models for Oral Biopharmaceutics: Evidence from an International Ring Study. [PDF]
O'Farrell C +19 more
europepmc +1 more source
The use of biorelevant dissolution media to forecast the in vivo performance of a drug. [PDF]
Klein S.
europepmc +1 more source
Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies. [PDF]
Laguna A +6 more
europepmc +1 more source
Structural Persistence Masks Commit-Point Chemical Transformation in Copper-Imidazolate Nanosheet Metal-Organic Frameworks. [PDF]
Chakraborty S +5 more
europepmc +1 more source
Breaking barriers: nanosystems to overcome solubility and permeability challenges of second-generation tyrosine kinase inhibitors. [PDF]
Shree B +4 more
europepmc +1 more source
Dissolution Profile of Tosufloxacin Tosylate in Biorelevant Bicarbonate Buffer Containing Sodium Chloride: Precipitation of Hemi-hydrochloride Salt at the Particle Surface. [PDF]
Okamoto N, Yamamoto H, Sugano K.
europepmc +1 more source
Impact of Permeation Enhancers on the Release of Insulin from Tablets in Biorelevant Media. [PDF]
Fagan A +4 more
europepmc +1 more source
Co-Amorphous Ursolic Acid-Quercetin Complex Improves Solubility and In Vivo Expectorant-Antitussive Activity. [PDF]
Jiang Y, Qiu Z, Lin B, Yang Z, Hong Y.
europepmc +1 more source

